Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma
西地尼布(一种口服全血管内皮生长因子受体酪氨酸激酶抑制剂)治疗复发性胶质母细胞瘤患者的 II 期研究
期刊:Journal of Clinical Oncology
影响因子:42.1
doi:10.1200/JCO.2009.26.3988
Tracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Scott R Plotkin, Elizabeth Gerstner, April F Eichler, Jan Drappatz, Fred H Hochberg, Thomas Benner, David N Louis, Kenneth S Cohen, Houng Chea, Alexis Exarhopoulos, Jay S Loeffler, Marsha A Moses, Percy Ivy, A Gregory Sorensen,